1
Clinical Trials associated with Fecal Microbiota Transplant(Boston Children's Hospital)A Phase I/II, Double Blinded, Placebo Controlled, Single-center Study of Fecal Microbiota Transplant (FMT) for the Treatment of Active Pediatric Ulcerative Colitis and Pediatric Active Crohn's Colitis
The primary aims of this phase I/II, randomized, placebo controlled study are the assessment of safety and tolerability of universal donor FMT compared to placebo in pediatric and young adult subjects (ages 5 years through 30 years) with active ulcerative colitis (UC) or active Crohn's colitis (CD) who have failed, are intolerant to, or have refused traditional first-line maintenance therapy. Secondary objectives include the identification biomarkers in both donor and recipient that may confer a clinical response and to establish whether or not ongoing FMT maintenance therapy is required for maintenance of clinical benefit in pediatric UC or pediatric CD.
100 Clinical Results associated with Fecal Microbiota Transplant(Boston Children's Hospital)
100 Translational Medicine associated with Fecal Microbiota Transplant(Boston Children's Hospital)
100 Patents (Medical) associated with Fecal Microbiota Transplant(Boston Children's Hospital)
100 Deals associated with Fecal Microbiota Transplant(Boston Children's Hospital)